Transdermal fentanyl for the treatment of pain caused by rheumatoid arthritis

Rheumatology International

Volumn 24, Issue 6, 2004, Pages 325-332

  Herrero Beaumont, Gabriel ^a   Bjorneboe, Olav ^b   Richarz, Ute ^c  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^b MARTINA HANSENS HOSPITAL   (Norway)

^c Janssen Cilag   (Switzerland)

Author keywords

Analgesia; Fentanyl; Opioids; Pain; Rheumatoid arthritis

Indexed keywords

ANALGESIC AGENT; FENTANYL; METOCLOPRAMIDE; OPIATE; SHORT ACTING DRUG;

ADULT; AGED; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CONSTIPATION; CONTROLLED STUDY; DISEASE SEVERITY; DIZZINESS; DRUG DOSE REDUCTION; DRUG MEGADOSE; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NAUSEA; OPIOID INDUCED EMESIS; PAIN; PERIPHERAL NEUROPATHY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PSYCHOLOGIC TEST; QUALITY OF LIFE; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; SOMNOLENCE; TRANSDERMAL PATCH; TREATMENT INDICATION;

ADMINISTRATION, CUTANEOUS; ARTHRITIS, RHEUMATOID; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FENTANYL; HUMANS; MALE; MULTIVARIATE ANALYSIS; PAIN; PAIN MEASUREMENT; PROBABILITY; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 15044354123     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-004-0520-7     Document Type: Article

References (28)

1. Markenson JA (1991) World-wide trends in the socio-economic impact and long term prognosis of rheumatoid arthritis. Semin Arthritis Rheum 21:4-12
2. Kalso E, Allan L, Dellemijn PL I, Faura CC, Ilias WK, Jensen TS, Perrot S, Plaghki LH, Zenz M (2003) Recommendations for using opioids in chronic non-cancer pain. Eur J Pain 7:381-386
3. Schug SA, Merry AF, Acland RH (1991) Treatment principles for the use of opioids in pain of nonmalignant origin. Drugs 42:228-239
4. Graziotti PJ, Goucke CR (1997) The use of oral opioids in patients with chronic non-cancer pain. Management strategies. Med J Aust 167:30-34
5. Anon (1997) The use of opioids for the treatment of chronic pain: a consensus statement from the American Academy of Pain Medicine and the American Pain Society. Pain Forum 6:77-79
6. Pendleton A, Arden N, Dougados M, Doherty M, Bannwarth B, Bijlsma JWJ, Cluzeau F, Cooper C, Dieppe PA, Günther K-P, Hauselmann HJ, Herrero-Beaumont G, Kaklamanis PM, Leeb B, Lequesne M, Lohmander S, Mazieres B, Mola E-M, Pavelka K, Serni U, Swoboda B, Verbruggen AA, Weseloh G, Zimmermann-Gorska I (2000) EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 59:936-944
7. Roth SH, Fleischmann RM, Burch FX, Dietz F, Bockow B, Rapoport RJ, Rutstein J, Lacouture PG (2000) Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: placebo-controlled trial and long-term evaluation. Arch Intern Med 160:853-860
8. Peloso PM, Bellamy N, Bensen W, Thomson GT, Harsanyi Z, Babul N, Darke AC (2000) Double blind randomized placebo control trial of controlled release codeine in the treatment of osteoarthritis of the hip or knee. J Rheumatol 27:764-771
9. Babul N, Noveck R, Chipman H, Roth SH, Gana T, Albert K (2004) Efficacy and safety of extended-release, once-daily tramadol in chronic pain: a randomized 12-week clinical trial in osteoarthritis of the knee. J Pain Symptom Manage 28:59-71
10. Griessinger N, Sittl R, Jost R, Schaefer M, Likar R (2003) The role of opioid analgesics in rheumatoid disease in the elderly population. Drugs Aging 20:571-583
11. Blomqvist P, Feltelius N, Ekbom A, Klareskog L (2000) Rheumatoid arthritis in Sweden. Drug prescriptions, costs and adverse drug reactions. J Rhematol 27:1171-1177
12. American Pain Society (2002) Guideline for the management of pain in osteoarthritis, rheumatoid arthritis, and juvenile chronic arthritis. http://www.ampainsoc.org
13. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324
14. Cleeland CS, Ryan KM (1994) Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore 23:129-138
15. Pavelka K, Le Loet X, Bjorneboe O, Herrero-Beaumont G. Benefits of transdermal fentanyl in patients with rheumatoid arthritis or with osteoarthritis of the knee or hip: an open-label study to assess pain control. Curr Med Res Opin (in preparation)
16. Ware JE, Sherbourne CD (1992) The MOS 36-item Short-Form Health Survey (SF-36). Med Care 30:473-483
17. Fries JF, Spitz P, Kraines RG, Holman HR (1980) Measurement of patient outcome in arthritis. Arthritis Rheum 23:137-145
18. Simpson RK, Edmondson EA, Constant CF, Collier C (1997) Transdermal fentanyl as treatment for chronic low back pain. J Pain Symptom Manage 14:218-224
19. Berliner M, Schwalen S, Seidel W, Hantzschel H (2002) Fentanyl-TTS in the treatment of pain caused by rheumatoid arthritis. Akt Rheumatol 27:230-235
20. Sherrer YS, Bloch DA, Mitchell DM, Young DY, Fries JF (1986) The development of disability in rheumatoid arthritis. Arthritis Rheum 29:494-500
21. Van Der Heide A, Jacobs JWG, Haanen HCM, Bijlsma JWJ (1995) Is it possible to predict the first year extent of pain and disability for patients with rheumatoid arthritis? J Rheumatol 22:1466-70
22. Portenoy RK (2000) Current pharmacotherapy of chronic pain. J Pain Symptom Manage 19:S16-S20
23. Allan LA, Kalso E on behalf of the FEN-INT-26 Study Group (2003) Randomised trial of transdermal fentanyl and sustained release oral morphine in chronic low back pain. Presented at the 4th Congress of the EFIC, Prague, 2-6 September 2003
24. Kosinski M, Zhao SZ, Dedhiya S, Osterhaus JT, Ware JE Jr (2000) Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis. Arthritis Rheum 43:1478-1487
25. Allen L, Hays H, Jensen NH, de Waroux BL, Bolt M, Donald R, Kalso E (2001) Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain. Br Med J 322:1154-1158
26. Dellemijn PLI, van Duijn H, Vanneste JAL (1998) Prolonged treatment with transdermal fentanyl in neuropathic pain. J Pain Symptom Manage 16:220-229
27. Ahmedzai S, Brooks D (1997) Transdermal fentanyl versus sustained release oral morphine in cancer pain: preference, efficacy and quality of life. J Pain Symptom Manage 13:254-261
28. Knott L (2000) Treating osteoarthritis in practice - the TOP study. Curr Med Res Opin 16:147-152